COVID-19 vaccine - VETAL
Alternative Names: Adjuvanted inactivated COVID-19 vaccine - VETALLatest Information Update: 28 May 2024
Price :
$50 *
At a glance
- Originator VETAL
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 May 2024 No recent reports of development identified for phase-I development in COVID-2019-infections(Prevention) in Turkey (SC, Injection)
- 17 May 2022 VETAL and The Scientific and Technological Research Council of Turkey terminate a phase-I trial in COVID-2019 infections (Prevention) in Turkey (SC) (NCT04866069)
- 25 Apr 2021 Phase-I clinical trials in COVID-2019 infections (Prevention) in Turkey (SC) (NCT04866069)